Page last updated: 2024-08-23

hydroxymethanediphosphonic acid and Cardiomyopathies

hydroxymethanediphosphonic acid has been researched along with Cardiomyopathies in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Bhatia, K; Campisi, R; Cuddy, S; Damy, T; Einstein, AJ; Gallegos-Kattan, C; Maurer, MS; McMahon, S; Miller, EJ; Shah, NR; Slart, RHJA1
Cuddy, SAM; Di Carli, MF; Dorbala, S; Falk, RH; Khor, YM; Singh, V1

Reviews

2 review(s) available for hydroxymethanediphosphonic acid and Cardiomyopathies

ArticleYear
Radiopharmaceutical supply disruptions and the use of
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2022, Volume: 29, Issue:5

    Topics: Amyloidosis; Cardiomyopathies; Diphosphates; Diphosphonates; Humans; Prealbumin; Radiopharmaceuticals; Technetium Tc 99m Pyrophosphate

2022
    Radiology, 2023, Volume: 306, Issue:2

    Topics: Amyloid Neuropathies, Familial; Amyloidosis; Cardiomyopathies; Heart; Humans; Prealbumin; Radionuclide Imaging; Radiopharmaceuticals

2023